United Therapeutics | UTHR - Assets



United Therapeutics reported $7.91B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Amarin USD 655.68M 29.67M Mar/2025
Ardelyx USD 466.77M 31.02M Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Bayer EUR 105.24B 3.95B Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
BioMarin Pharmaceutical USD 7.46B 309.33M Jun/2025
Gilead Sciences USD 55.72B 713M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Halozyme Therapeutics USD 2.05B 142.63M Jun/2025
Insmed USD 2.48B 677.12M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Moderna USD 12.01B 694M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
PTC Therapeutics USD 2.63B 21.23M Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Sarepta Therapeutics USD 3.68B 214.43M Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025
United Therapeutics USD 7.91B 164.1M Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025